Bandingkan Harga & Kinerja Champion Pacific Indonesia Tbk. (IGAR) vs Reksa Dana Syariah BRI MI Gold ETF Syariah (XDES)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Champion Pacific Indonesia Tbk. dan Reksa Dana Syariah BRI MI Gold ETF Syariah: Champion Pacific Indonesia Tbk. diperdagangkan di Rp444 (kapitalisasi pasar 411,93 M, volume 24 jam 48,4 rb), sedangkan Reksa Dana Syariah BRI MI Gold ETF Syariah diperdagangkan di Rp1.020 (kapitalisasi pasar 1,74 M, volume 24 jam 328,4 rb). Perbedaan utamanya: Champion Pacific Indonesia Tbk. jauh lebih besar — sekitar 236,7× kapitalisasi pasar Reksa Dana Syariah BRI MI Gold ETF Syariah, dan Reksa Dana Syariah BRI MI Gold ETF Syariah lebih aktif diperdagangkan (328,4 rb vs 48,4 rb). Mana yang lebih baik tergantung tujuan investasimu.
| IGAR | XDES | |
|---|---|---|
Kapitalisasi Pasar | 411,93 M | 1,74 M |
Volume | 48,4 rb | 328,4 rb |
Lot | 484 | 3,28 rb |
Perputaran | 21,53 jt | 338,05 jt |
Harga Rata-rata | 444,77 | 1.029,37 |
Nilai Transaksi | 21,53 jt | 338,05 jt |
Harga Ekuilibrium Indikatif | — | 1.020 |
Volume Ekuilibrium Indikatif | — | 10 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Champion Pacific Indonesia Tbk.
PT Champion Pacific Indonesia Tbk (The Company) formerly PT Kageo Igar Jaya was established under the name of PT Igar Jaya based on Notarial deed No. 195 dated October 30, 1975, of Mohamad Said Tadjoedin, SH, Notary in Jakarta. Igar Jaya was founded in October 1975 in the Republic of Indonesia as a joint venture with Owens-Illinois, a leading glass container manufacturer in the United States, initially in the production of glass vial and ampoules to support Indonesia’s pharmaceutical industry. However since 1987, due to customer demand, the Company has expanded to the business of plastic, aluminum foil (flexible packaging) and paper folding carton packaging products as well as disposable syringe not only to meet the needs of Indonesia’s pharmaceutical industry but also its cosmetic and food industries. In 1988, the Company relinquished its joint venture status with a view to entering the global market and today has customers in 14 countries outside Indonesia. These include: Britain, Bangladesh, Canada, Guinea, Malaysia, Mauritius, Pakistan, the Philippines, Saudi Arabia, Singapore, Thailand, Trinidad & Tobago, the United States and Zaire.
Selengkapnya di halaman IGAR →
